Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
1.660
0.00 (0.00%)
At close: Aug 25, 2026, 4:00 PM EDT
1.650
-0.010 (-0.60%)
After-hours: Aug 25, 2026, 4:10 PM EDT
Rapid Micro Biosystems Revenue
Rapid Micro Biosystems had revenue of $8.05M in the quarter ending June 30, 2026, with 10.91% growth. This brings the company's revenue in the last twelve months to $35.18M, up 16.13% year-over-year. In the year 2025, Rapid Micro Biosystems had annual revenue of $33.59M with 19.74% growth.
Revenue (ttm)
$35.18M
Revenue Growth
+16.13%
P/S Ratio
2.35
Revenue / Employee
$205,708
Employees
171
Market Cap
83.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.59M | 5.54M | 19.74% |
| Dec 31, 2024 | 28.05M | 5.53M | 24.57% |
| Dec 31, 2023 | 22.52M | 5.39M | 31.44% |
| Dec 31, 2022 | 17.13M | -6.10M | -26.25% |
| Dec 31, 2021 | 23.23M | 7.16M | 44.50% |
| Dec 31, 2020 | 16.08M | -435.00K | -2.63% |
| Dec 31, 2019 | 16.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.80M |
| Pulmonx | 87.44M |
| CVRx, Inc. | 61.19M |
| LENSAR | 60.26M |
| Myomo | 43.26M |
| electroCore | 36.97M |
| Hyperfine | 16.54M |
| Nano-X Imaging | 14.52M |
RPID News
- 18 days ago - Rapid Micro Biosystems Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - Rapid Micro Biosystems Earnings release: Q2 2026 - Filings
- 18 days ago - Rapid Micro Biosystems Quarterly report: Q2 2026 - Filings
- 18 days ago - Rapid Micro Biosystems reports Q2 EPS (27c), consensus (24c) - TheFly
- 18 days ago - Rapid Micro Biosystems backs FY26 revenue view $37M-$41M, consensus $39.3M - TheFly
- 18 days ago - Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 21 days ago - Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026 - GlobeNewsWire